Insights on the Contrast Media Global Market to 2027 - Featuring Bayer, GE Healthcare and Guerbet Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Contrast Media - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Contrast Media estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$5.6 Billion by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027.

X-ray/Computed Tomography (CT), one of the segments analyzed in the report, is projected to record a 1.6% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Magnetic Resonance Imaging (mri) segment is readjusted to a revised 3.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 4.3% CAGR

The Contrast Media market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$350.6 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 2.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Ultrasound Segment to Record 4.1% CAGR

In the global Ultrasound segment, USA, Canada, Japan, China and Europe will drive the 4.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$989.3 Million in the year 2020 will reach a projected size of US$1.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$299.9 Million by the year 2027, while Latin America will expand at a 3.9% CAGR through the analysis period.

Select Competitors (Total 45 Featured) -

• AMAG Pharmaceuticals, Inc.
• Bayer AG
• Daiichi Sankyo Co., Ltd.
• GE Healthcare
• Guerbet Group
• Starpharma Holdings Limited

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• Impact of Covid-19 and a Looming Global Recession
• Prevalence of Chronic Diseases Among the Growing Global Population Pushes Up the Diagnostic Burden & Demand for Imaging
• Rising Prevalence of Chronic Diseases Amplifies the Volume of Imaging Procedures, Driving Opportunities for Imaging Agents: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
• The US$ 37 Billion Robustly Growing Medical Imaging Market Provides Lucrative Opportunities for Contrast Agents for Advanced Visualization: Global Medical Imaging Market (In US$ Billion) for the Years 2018, 2020 and 2022
• Aging Population, a Demographic Catalyst Driving Demand for Imaging Services
• Rapidly Aging Population & the Challenges Associated With Geriatric Imaging Spurs Demand for Contrast Imaging Agents: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
• Rise of Nuclear Medicine, the Cornerstone for the Growth for Radioactive Tracers
• Improving Quality & Value of Nuclear Medicine Bodes Well for Radioactive Contrast Agents: Global Market for Nuclear Imaging (US$ Billion) for the Years 2018, 2020, 2022 and 2025 by Type

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images
• With "Value" being the new Currency in Healthcare Markets Worldwide, Value Based Imaging Will Positively Impact Contrast Enhanced Imaging Procedures: % of Value-Based Reimbursement (VBR) & Fee-For-Service Structured Healthcare Organizations for the Years 2016, 2018 and 2022
• Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI
• Commercially Available MRI Contrast Agents
• Spurred by Safety & Efficiency Benefits, Growing MRI Procedures & Parallel Increase in MRI Machines to Benefit Demand for MRI Contrast Agents: Global MRI Equipment Market (In US$ Billion) for the Years 2018, 2020, 2022 and 2024
• Equipment Density Correlates With Number of Imaging Procedures: Magnetic Resonance Imaging (MRI) Units in Select Countries (Per Million Population) for the Year 2019
• Evolving Clinical Applications of Contrast-Enhanced Ultrasound (CEUS) Drive Demand for Ultrasound Contrast Agents
• Clinically Available Ultrasound Contrast Agents
• Growing Use of CEUS in Emergency and Critical Care
• Special Focus on Microbubble Contrast Agents for Ultrasound Imaging
• Clinical Applications of Microbubbles
• Oscillating Microbubbles: To Revolutionize Ultrasound
• Growing Market for Ultrasound Equipment Pushes Up the Number of CEUS Procedures Performed: Global Market for Ultrasound Equipment (In US Billion) for the Years 2017, 2019, 2022 and 2024
• Continued Value of CT Imaging in Cardiology Despite Risk of Radiation Exposure Drives Demand for Contrast-Enhanced CT
• Contrast Agents Used in CT Imaging by Class: A Snapshot
• CCTA Gaining Traction in Coronary Arteries Imaging
• List of Iodine-Containing Contrast Agents for Coronary CT Angiography
• Growing Access to CT Imaging Bodes Well for CT Contrast Agents: Density of CT Scanners in Select Countries (Per Million Population) for the Year 2019
• Rise in Image Guided Surgeries Drives Demand for Contrast Agents
• Emergence of Molecular-Targeted Fluorescent Tracers
• Select Potential "always-on" Targeted Tracers for Fluorescence Image-Guided Surgery (FIGS)

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/4ii23g